Lataa...
Safety of Non-Vitamin K Oral Anticoagulants in Elderly Patients with Atrial Fibrillation
Aim. To study the safety of non-vitamin K oral anticoagulants (NOAC) in patients with atrial fibrillation (AF) over 75 years old.Material and methods. The observation study included patients ≥75 years of age with confirmed AF, receiving dabigatran in a reduced dosage, apixaban or rivaroxaban in full...
Tallennettuna:
Päätekijät: | , , , , |
---|---|
Aineistotyyppi: | Artigo |
Kieli: | Inglês |
Julkaistu: |
Stolichnaya Izdatelskaya Kompaniya
2020-01-01
|
Sarja: | Racionalʹnaâ Farmakoterapiâ v Kardiologii |
Aiheet: | |
Linkit: | https://www.rpcardio.com/jour/article/view/2071 |
Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|